What is China Resources Medical Holdings Co PB Ratio?
China Resources Medical Holdings CoCMHDF 88 PB Ratio is 0.79 as of Jun. 29, 2026, which is 13% below its 10-year median of 0.91. GuruFocus rates CMHDF with a GF Score™ of 88/100 and a GF Value™ of $0.95. The stock has 5 warning signs investors should review. Among 608 Healthcare Providers & Services companies, China Resources Medical Holdings Co ranks better than 95.07% on this metric.
CMHDF's PB Ratio is ranked better than 95.07% of 608
companies
in the Healthcare Providers & Services industry
Industry Median: 1.985
vs CMHDF: 0.42
During the past 12 months, China Resources Medical Holdings Co's average Book Value Per Share Growth Rate was 9.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -11.20% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -2.30% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 5.50% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of China Resources Medical Holdings Co was 51.50% per year. The lowest was -11.20% per year. And the median was 7.50% per year.
Back to Basics: PB Ratio
China Resources Medical Holdings Co (OTCPK:CMHDF) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
China Resources Medical Holdings Co PB Ratio Related Terms
China Resources Medical Holdings Co PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Resources Medical Holdings Co PB Ratio Chart
For the Medical Care Facilities subindustry, China Resources Medical Holdings Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Resources Medical Holdings Co PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, China Resources Medical Holdings Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where China Resources Medical Holdings Co's PB Ratio falls into.
China Resources Medical Holdings Co PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
China Resources Medical Holdings Co (CMHDF) has a PB Ratio of 0.79 as of Jun. 29, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on China Resources Medical Holdings Co and its competitors. This is 13% below median its historical median of 0.91. Over the past decade, China Resources Medical Holdings Co's PB Ratio has ranged from 0.42 to 5.49. According to the industry distribution chart, China Resources Medical Holdings Co ranks #30 out of 608 companies in the Healthcare Providers & Services industry, placing it in the top 4.9%.
Is China Resources Medical Holdings Co's PB Ratio too high?
China Resources Medical Holdings Co's current PB Ratio of 0.79 is 13% below median its 10-year median of 0.91. Over the past 10 years, this metric has ranged from a low of 0.42 to a high of 5.49. The Healthcare Providers & Services industry median PB Ratio is 1.99. China Resources Medical Holdings Co's value of 0.79 is 60.2% below this industry median. Based on the distribution chart, China Resources Medical Holdings Co ranks #30 out of 608 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, China Resources Medical Holdings Co has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does China Resources Medical Holdings Co's PB Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, China Resources Medical Holdings Co ranks #30 out of 608 companies for PB Ratio. This places China Resources Medical Holdings Co in the top 5% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.99. China Resources Medical Holdings Co's value of 0.79 is 60.2% below this benchmark. Historically, China Resources Medical Holdings Co's own PB Ratio has ranged from 0.42 to 5.49 over the past decade. While the company's 10-year median is 0.91 vs. the industry median of 1.99, China Resources Medical Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.99, based on 608 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Resources Medical Holdings Co's current PB Ratio of 0.79 is 60.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on China Resources Medical Holdings Co and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Resources Medical Holdings Co's current PB Ratio is 0.79, which is 13% below median its own 10-year median of 0.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Resources Medical Holdings Co stock overvalued right now?
China Resources Medical Holdings Co (CMHDF) has a current PB Ratio of 0.79. The stock's GF Value™ is $0.95, compared to a current price of $0.58 — trading 38.9% below its estimated fair value. The current PB Ratio is 0.79, which is 13% below median its 10-year median of 0.91 and 60.2% below the Healthcare Providers & Services industry median of 1.99. China Resources Medical Holdings Co's overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For China Resources Medical Holdings Co (CMHDF), the current PB Ratio is 0.79 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Resources Medical Holdings Co (CMHDF) Overvalued in 2026?
Based on GuruFocus' analysis, China Resources Medical Holdings Co stock appears to be undervalued.
The current stock price of $0.58 is trading 38.9% below its estimated GF Value™ of $0.95.
Key valuation signals for CMHDF:
PB Ratio: 0.79 (13% below median its 10-year median of 0.91)
GF Value™: $0.95 vs. price of $0.58 (38.9% below fair value)
Industry Position: 60.2% below the Healthcare Providers & Services median (#30 of 608)
No single metric tells the full story. See the CMHDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Resources Medical Holdings Co Business Description
China Resources Medical Holdings Co Ltd is engaged in the provision of general healthcare services; provision of hospital management services, sale of pharmaceuticals, medical devices, and medical consumables, and provision of other services in the Chinese Mainland. The group has two operating segments: Hospital Business and Other Business. The Hospital Business segment includes outpatient business and inpatient business corresponding to self-owned hospitals. The Other business segment includes operation management services, supply chain services, and other ancillary services provided to participating hospitals and IOT/OT hospitals. It generates the majority of its revenue from the Hospital Business segment.
88GF Score
Get the complete analysis for CMHDF
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CMHDF has been successfully added to your 
